aDepartment of Pediatric Hematology and Oncology

bDepartment of Pharmacology, Sakarya University Faculty of Medicine, Sakarya, Turkey

Received 1 June 2022 Accepted as revised 20 February 2023.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website, www.behaviouralpharm.com.

Correspondence to Mustafa Büyükavci, MD, Department of Pediatric Hematology and Oncology, Sakarya University School of Medicine, Adnan Menderes Caddesi Sağlik Sokak No: 195, 54000, Adapazari, Sakarya, Sakarya, Turkey, E-mail: [email protected]